Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

IGC Pharma (IGC) Long-Term Debt Issuances (2020)

IGC Pharma (IGC) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $580000.0 as the latest value for Q2 2020.

  • Quarterly Long-Term Debt Issuances changed N/A to $580000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $580000.0 through Jun 2021, changed 0.0% year-over-year, with the annual reading at -$21849.0 for FY2014, 109.74% down from the prior year.
  • Long-Term Debt Issuances for Q2 2020 was $580000.0 at IGC Pharma, up from -$309050.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $580000.0 in Q2 2020, with the low at $580000.0 in Q2 2020.